Immunocore Holdings IMCR
NASDAQ IMCR
$29.71 -0.83 (-2.72%)
At close: Oct 2, 2026 · 4:00 PM EDT

Immunocore Holdings (IMCR) Interest & Investment Income (2021 - 2026)

Updated

Immunocore Holdings (IMCR) recorded Interest & Investment Income of $3.58 million in Q2 2026, down 16.1% from $4.27 million a year earlier but up 4.8% from the prior quarter.

Analysis

Immunocore Holdings (IMCR) Interest & Investment Income (2021 - 2026) Analysis & Trends

On a TTM basis, Immunocore Holdings' Interest & Investment Income came in at $15.03 million as of Jun 30, 2026, down 23.2% year-over-year; for FY2025, it was $16.48 million, down 35.7% from FY2024.

  • Annual Interest & Investment Income has a five-year compound annual growth rate of 41.4% (FY2020 to FY2025).
  • Across earlier years, Interest & Investment Income came in at $25.62 million in FY2024 (+42.4%), $17.99 million in FY2023 (+378.9%), $3.76 million in FY2022 and $65,000 in FY2021 (-97.8%).
  • Quarterly Interest & Investment Income has ranged from $6,740 in Q4 2021 to $8.25 million in Q1 2024 over the past five years.
  • On a year-over-year basis, Interest & Investment Income has declined for seven consecutive quarters, with an average decline of 19.9% over the last eight quarters.
  • Peak year-over-year performance for Interest & Investment Income in the last five years was growth of 630.8% in Q3 2023, against a decline of 49.4% in Q1 2025 at the low end.
  • Per Business Quant, the preceding three quarters came in at $3.42 million (Q1 2026), $3.91 million (Q4 2025) and $4.12 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 219.00 Mn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 80.00 Mn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 Immunocore Holdings 1.53 Bn -1.95 Bn 114.84 Mn 3.58 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.58 Mn
Mar 31, 2026 3.42 Mn
Dec 31, 2025 3.91 Mn
Sep 30, 2025 4.12 Mn
Jun 30, 2025 4.27 Mn
Mar 31, 2025 4.18 Mn
Dec 31, 2024 5.17 Mn
Sep 30, 2024 5.96 Mn
Jun 30, 2024 6.24 Mn
Mar 31, 2024 8.25 Mn
Dec 31, 2023 5.44 Mn
Sep 30, 2023 5.14 Mn
Jun 30, 2023 4.28 Mn
Mar 31, 2023 3.13 Mn
Dec 31, 2022 2.85 Mn
Sep 30, 2022 703,593.33
Jun 30, 2022 148,599.08
Dec 31, 2021 6,740.05
Sep 30, 2021 11,028.67
API Access

Immunocore Holdings Interest & Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=IMCR&period=max&api_key=YOUR_API_KEY